NFIL remains excited on new opportunities and plans for a new innovation centre outside India
Industrial exhaust gas used to produce sustainable alcohol
Hexion’s commitment encompasses “Scope 1” and “Scope 2” emissions, which are direct and indirect greenhouse emissions from operations and consumed energy
The transaction is subject to customary regulatory approval and is expected to close in the second half of 2021
For the first time in its history, Sadara’s net profits after Zakat & Tax in this first quarter exceeded SAR 1.6 billion
Higher sales volume, particularly in engineered materials and synthetic rubber
MSIL and its vendors will procure oxygen plants from these two companies and donate them for medical use
The company proactively took certain systems offline to contain the threat which has temporarily halted all pipeline operations, and affected some of their IT systems
Trials for vaccine delivery using drones may commence by the end of May 2021
The drug accumulates in the virus infected cells and prevents virus growth by stopping viral synthesis and energy production
Industry might reduce production as well as import of Di-ammonium Phosphate and shift focus towards other grades of phosphatic fertilizers
Evonik is more positive about its earnings for the year as a whole after posting a strong first quarter
State governments and UTs have been asked to monitor proper distribution within the state/UT covering government and private hospitals
ULTRASIL 4000 GR is the first low surface area silica with very good dispersibility
Operating income is expected to increase in all segments excepting the others segment
ICICI Direct expects the pharma segment to grow at 15% CAGR in FY21-23E to Rs 1407 crore
Jubilant successfully challenged Bracco's patent infringement claims in an Inter Parties Review (IPR) proceeding before the U.S. Patent Office
Baricitinib was issued a restricted emergency use approval by the Central Drugs Standard Control Organization (CDSCO)
Baricitinib is used in combination with remdesivir for the treatment of suspected or laboratory confirmed COVID-19
Baricitinib is an oral medication that was earlier registered in India for the treatment of moderate to severe active rheumatoid arthritis in adult patients.
Subscribe To Our Newsletter & Stay Updated
